Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
25.58
-0.35 (-1.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
November 30, 2023
From
Guardant Health, Inc.
Via
Business Wire
Jim Cramer: Buy This Financial Stock, 'It's Up Substantially From Where It Was In The Spring'
November 28, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he remains a buyer of SoFi Technologies, Inc. (NASDAQ: SOFI).
Via
Benzinga
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2023
From
Guardant Health, Inc.
Via
Business Wire
Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today?
November 15, 2023
Guardant Health Inc (NASDAQ: GH) shares are falling after the company announced it intends to appeal its verdict in the U.S.
Via
Benzinga
7 Analysts Have This to Say About Guardant Health
November 13, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
The Latest Analyst Ratings for Guardant Health
October 20, 2023
Via
Benzinga
Guardant Health to Appeal Federal District Court Verdict
November 15, 2023
From
Guardant Health, Inc.
Via
Business Wire
Cancer Test Firm Guardant Health Posts Smaller Than Expected Q3 Loss, Lifts Annual Sales Outlook
November 07, 2023
Guardant Health Inc (NASDAQ: GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million
Via
Benzinga
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
November 06, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming November Investor Conferences
November 03, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® Platform
October 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Why Guardant Health Stock Popped Again Today
September 28, 2023
Wall Street loves this unprofitable biotech.
Via
The Motley Fool
Bull Of The Day: NeoGenomics
October 24, 2023
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.
Via
Talk Markets
First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer
October 23, 2023
From
Guardant Health, Inc.
Via
Business Wire
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
October 17, 2023
EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END
Via
FinancialNewsMedia
Analyst Expectations for Guardant Health's Future
September 27, 2023
Via
Benzinga
Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023
From
Guardant Health, Inc.
Via
Business Wire
1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years
October 11, 2023
This company's fight against a deadly disease could pay off.
Via
The Motley Fool
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
October 08, 2023
The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.
Via
The Motley Fool
Why Guardant Health Stock Jumped 15% This Week
September 28, 2023
The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.
Via
The Motley Fool
Guardant Health Has 'Underlying Business Strength' Says This Bullish Analyst
September 27, 2023
Shares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases
September 26, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 26, 2023 – USA News Group – The seriousness of pancreatic cancer continues to grow, with increasing alarm since The...
Via
FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan
September 06, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
September 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
September 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.